Cargando…
ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group’s perspective
There has been no major change of practice in gastrointestinal oncology at the European Society for Medical Oncology (ESMO) symposium 2021, but confirmation that immunotherapy in combination with chemotherapy has become standard of care in several indications. The European Organisation for Research...
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857487/ https://www.ncbi.nlm.nih.gov/pubmed/35180656 http://dx.doi.org/10.1016/j.esmoop.2022.100392 |
| _version_ | 1784654052362027008 |
|---|---|
| author | Koessler, T. Alsina, M. Arnold, D. Ben-Aharon, I. Collienne, M. Lutz, M.P. Neuzillet, C. Obermannova, R. Peeters, M. Sclafani, F. Smyth, E. Valle, J.W. Wagner, A.D. Wyrwicz, L. Fontana, E. Moehler, M. |
| author_facet | Koessler, T. Alsina, M. Arnold, D. Ben-Aharon, I. Collienne, M. Lutz, M.P. Neuzillet, C. Obermannova, R. Peeters, M. Sclafani, F. Smyth, E. Valle, J.W. Wagner, A.D. Wyrwicz, L. Fontana, E. Moehler, M. |
| author_sort | Koessler, T. |
| collection | PubMed |
| description | There has been no major change of practice in gastrointestinal oncology at the European Society for Medical Oncology (ESMO) symposium 2021, but confirmation that immunotherapy in combination with chemotherapy has become standard of care in several indications. The European Organisation for Research and Treatment of Cancer (EORTC) Gastrointestinal Track Cancer Group has selected important phase II and III trials presented during the symposium across all gastrointestinal cancers as well as early reports on new drugs or new combinations that may change practice in the future. |
| format | Online Article Text |
| id | pubmed-8857487 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88574872022-03-02 ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group’s perspective Koessler, T. Alsina, M. Arnold, D. Ben-Aharon, I. Collienne, M. Lutz, M.P. Neuzillet, C. Obermannova, R. Peeters, M. Sclafani, F. Smyth, E. Valle, J.W. Wagner, A.D. Wyrwicz, L. Fontana, E. Moehler, M. ESMO Open Review There has been no major change of practice in gastrointestinal oncology at the European Society for Medical Oncology (ESMO) symposium 2021, but confirmation that immunotherapy in combination with chemotherapy has become standard of care in several indications. The European Organisation for Research and Treatment of Cancer (EORTC) Gastrointestinal Track Cancer Group has selected important phase II and III trials presented during the symposium across all gastrointestinal cancers as well as early reports on new drugs or new combinations that may change practice in the future. Elsevier 2022-02-16 /pmc/articles/PMC8857487/ /pubmed/35180656 http://dx.doi.org/10.1016/j.esmoop.2022.100392 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Review Koessler, T. Alsina, M. Arnold, D. Ben-Aharon, I. Collienne, M. Lutz, M.P. Neuzillet, C. Obermannova, R. Peeters, M. Sclafani, F. Smyth, E. Valle, J.W. Wagner, A.D. Wyrwicz, L. Fontana, E. Moehler, M. ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group’s perspective |
| title | ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group’s perspective |
| title_full | ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group’s perspective |
| title_fullStr | ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group’s perspective |
| title_full_unstemmed | ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group’s perspective |
| title_short | ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group’s perspective |
| title_sort | esmo congress 2021: highlights from the eortc gastrointestinal tract cancer group’s perspective |
| topic | Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857487/ https://www.ncbi.nlm.nih.gov/pubmed/35180656 http://dx.doi.org/10.1016/j.esmoop.2022.100392 |
| work_keys_str_mv | AT koesslert esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT alsinam esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT arnoldd esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT benaharoni esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT colliennem esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT lutzmp esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT neuzilletc esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT obermannovar esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT peetersm esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT sclafanif esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT smythe esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT vallejw esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT wagnerad esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT wyrwiczl esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT fontanae esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective AT moehlerm esmocongress2021highlightsfromtheeortcgastrointestinaltractcancergroupsperspective |